Does CABOTEGRAVIR Cause Lung neoplasm malignant? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Lung neoplasm malignant have been filed in association with CABOTEGRAVIR (Apretude). This represents 0.1% of all adverse event reports for CABOTEGRAVIR.
6
Reports of Lung neoplasm malignant with CABOTEGRAVIR
0.1%
of all CABOTEGRAVIR reports
4
Deaths
3
Hospitalizations
How Dangerous Is Lung neoplasm malignant From CABOTEGRAVIR?
Of the 6 reports, 4 (66.7%) resulted in death, 3 (50.0%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CABOTEGRAVIR Cause?
Product dose omission issue (1,121)
Off label use (1,049)
Injection site pain (924)
Viral load increased (452)
Pain (399)
Virologic failure (275)
Pathogen resistance (270)
Pyrexia (255)
Product use in unapproved therapeutic environment (234)
Inappropriate schedule of product administration (228)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which CABOTEGRAVIR Alternatives Have Lower Lung neoplasm malignant Risk?
CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE
CABOTEGRAVIR vs CABOZANTINIB
CABOTEGRAVIR vs CABOZANTINIB S-MALATE
CABOTEGRAVIR vs CAFFEINE
CABOTEGRAVIR vs CALASPARGASE PEGOL